EMJ’s Post

Have you listened to our latest #Podcast? Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer Listen now: https://lnkd.in/dEM8G7_8 #MedEd #EndometrialCancer #Immunotherapy #Oncology #MedicalEducation #CancerTreatment

How can AI make a difference in breast cancer research? Find out in this second instalment of Sofia Merajver's podcast with EMJ: https://hubs.la/Q02sG57C0 In this episode, Sofia and host Jonathan Sackier discuss precision medicine for oncology, advances on the horizon of breast cancer treatment and much more. #Oncology #BreastCancer #AI #CancerResearch #Cancer

Attention Oncologist and Researchers! Are you ready to share your groundbreaking research? Journal of Cancer Therapy and Research is now accepting submissions for its upcoming issue. We welcome original research articles, review articles, case reports, and clinical studies in all areas . Join a global community of experts and contribute to advancing the field. Submit your paper today: #CallForPapers #Research #cancer #oncology #oncologist

An approximately 65-year-old female with metastatic breast cancer underwent sequential 18F-FES and 18F-FDG PET/CT imaging on Biograph Vision™ PET/CT to assess the extent of disease and estrogen-receptor (ER) status. Read the case to learn how 18F-FES PET/CT was utilized in the evaluation of metastatic disease burden to help inform therapy treatment planning: https://lnkd.in/eBY-p3VK #siemenshealthineers #molecularimaging #oncology #breastcancer USA link: https://lnkd.in/e-ZsquhR 

Explore the critical role of circulating Tumor DNA (ctDNA) in breast cancer surveillance with insights from Dr. Barry Rosen, Breast Surgical #Oncologist and Senior Medical Advisor for Learn Look Locate. Barry Rosen Natera This guide delves into #ctDNA’s impact on monitoring and detecting cancer recurrence, featuring advancements like the groundbreaking Signatera™ technology. Essential for breast cancer survivors, it offers understanding and reassurance in managing breast cancer’s journey. #sponsored #physcians #cancerresearch #oncology #womenempoweringwomen https://lnkd.in/e7rq2FyY

Explore the transformative impact of MammaTyper® for breast cancer clinicians and patients in our latest short film.  Renowned experts in the field delve into key benefits, highlighting its robust evidence base, affordability, and efficiency. MammaTyper® accurately matches breast cancer patients with life-saving treatment, as emphasized by Dr. Dario de Biase: "MammaTyper® can analyze a wide array of markers simultaneously, eliminating the need for sequential analysis." Join the conversation: #CancerDiagnostics #Pathology #Oncology #HealthInnovation

Important to increase awareness and know the challenges regarding the increasing number of Liquid Biopsies - Pashtoon Kasi https://lnkd.in/gr46UBt7 #oncodaily #oncology #cancer #research

Explore the strategies for managing early-stage breast cancer in this insightful interview with Dr.Nataraj Naidu. Gain valuable insights into the diagnosis, treatment options, adjuvant therapy, and management of side effects associated with early breast cancer. Don't miss this opportunity to learn about managing early breast cancer from Dr. Nataraj Naidu! #BreastCancerAwareness #EarlyBreastCancer #CancerManagement #MedSynapse #HealthcareInsights #Oncology #AdjuvantTherapy #TreatmentSideEffects https://lnkd.in/dSVZWKhu

Since embarking on the breathtaking and uncanny road of cancer research, I've found myself profoundly devoted to this field of biology & medicine. Currently, I am beyond excited to announce that my debut narrative article, entitled "The Therapeutic Impact of Programmed Death-1 in the Treatment of Colorectal Cancer," has been published in the journal "Pathology - Research and Practice." An unbounded journey lies ahead, presenting endless opportunities to expand my knowledge. https://lnkd.in/eTZvZVeq #Oncology, #colorectal_cancer, #colorectalcancer,#cancer

We're happy to be here on the second day of #ESMOBreast24. Yesterday was great and we're looking forward to talking to even more clinicians and experts. We'd love to chat more about: Ki67 as a predictor of recurrence-free survival in breast cancer.  #BreastCancer #Oncology